![Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity - Kim - 2019 - Arthritis & Rheumatology - Wiley Online Library Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity - Kim - 2019 - Arthritis & Rheumatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/15d97502-ffa9-402b-a349-2d48364f8ed8/art40747-fig-0003-m.jpg)
Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity - Kim - 2019 - Arthritis & Rheumatology - Wiley Online Library
![PDF] Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness | Semantic Scholar PDF] Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d4a8c77ff85aa1fdad67620b0aea7f1405127ed2/9-Figure1-1.png)
PDF] Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness | Semantic Scholar
![Biomolecules | Free Full-Text | Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage Biomolecules | Free Full-Text | Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage](https://www.mdpi.com/biomolecules/biomolecules-10-01641/article_deploy/html/images/biomolecules-10-01641-g001-550.jpg)
Biomolecules | Free Full-Text | Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage
![Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis - eBioMedicine Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis - eBioMedicine](https://www.thelancet.com/cms/attachment/cb984d9d-5c81-463d-b03e-3d380f9c4749/fx1_lrg.jpg)
Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis - eBioMedicine
Serological and Genetic Evidence for Altered Complement System Functionality in Systemic Lupus Erythematosus: Findings of the GAPAID Consortium | PLOS ONE
![Complement Consumption in Systemic Lupus Erythematosus Leads to Decreased Opsonophagocytosis In Vitro | The Journal of Rheumatology Complement Consumption in Systemic Lupus Erythematosus Leads to Decreased Opsonophagocytosis In Vitro | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/45/11/1557/F1.large.jpg)
Complement Consumption in Systemic Lupus Erythematosus Leads to Decreased Opsonophagocytosis In Vitro | The Journal of Rheumatology
![Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus | Nature Reviews Rheumatology Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus | Nature Reviews Rheumatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fncprheum0191/MediaObjects/41584_2006_Article_BFncprheum0191_Fig1_HTML.jpg)